切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 358 -361. doi: 10.3877/cma.j.issn.2095-3232.2019.04.018

所属专题: 文献

临床研究

中性粒细胞/淋巴细胞比值联合CA19-9对肝内胆管癌的诊断价值
陈亚琼1, 田琪2, 龚娇1, 杜龙庭1, 张彤3,()   
  1. 1. 510630 广州,中山大学附属第三医院检验科
    2. 510630 广州,中山大学附属第三医院产科
    3. 510630 广州,中山大学附属第三医院肝移植科
  • 收稿日期:2019-05-05 出版日期:2019-08-10
  • 通信作者: 张彤
  • 基金资助:
    器官移植临床医学研究中心培育项目(2017B020209004)

Diagnostic value of neutrophil/lymphocyte ratio combined with CA19-9 for intrahepatic cholangiocarcinoma

Yaqiong Chen1, Qi Tian2, Jiao Gong1, Longting Du1, Tong Zhang3,()   

  1. 1. Department of Clinical Laboratory, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Obstetrics, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    3. Department of Liver Transplantation, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2019-05-05 Published:2019-08-10
  • Corresponding author: Tong Zhang
  • About author:
    Corresponding author: Zhang Tong, Email:
引用本文:

陈亚琼, 田琪, 龚娇, 杜龙庭, 张彤. 中性粒细胞/淋巴细胞比值联合CA19-9对肝内胆管癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2019, 08(04): 358-361.

Yaqiong Chen, Qi Tian, Jiao Gong, Longting Du, Tong Zhang. Diagnostic value of neutrophil/lymphocyte ratio combined with CA19-9 for intrahepatic cholangiocarcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(04): 358-361.

目的

探讨中性粒细胞/淋巴细胞比值(NLR)联合CA19-9在肝内胆管癌(ICC)中的诊断价值。

方法

本研究对象为2012年1月至2017年10月在中山大学附属第三医院确诊为ICC的70例患者(胆管癌组),同期胆管良性病变患者80例(良性病变组)及健康体检者80例(对照组)。患者均签署知情同意书,符合医学伦理学规定。其中胆管癌组男44例,女26例;平均年龄(54±12)岁。良性病变组男54例,女26例;年龄(55±13)岁。对照组男52例,女28例;年龄(51±10)岁。收集患者初次入院的血常规、CA19-9及CA125,计算NLR和血小板/淋巴细胞比值(PLR)。采用受试者工作特征(ROC)曲线分析各指标单独和联合检测诊断ICC的效能。

结果

NLR、PLR、CA19-9及CA125诊断ICC的ROC曲线下面积分别为0.848、0.780、0.881及0.860,诊断界值分别为2.3、168、19 kU/L、21 kU/L。NLR、PLR、CA19-9及CA125敏感度分别为0.81、0.51、0.74、0.67,特异度为0.86、0.91、0.98、0.90。NLR+PLR、NLR+CA19-9、NLR+CA125、CA19-9+CA125联合检测ROC曲线下面积分别为0.857、0.963、0.927、0.938,敏感度为0.86、0.96、0.93、0.89,特异度为0.81、0.88、0.84、0.88。

结论

单独检测NLR、PLR、CA19-9、CA125对肝内胆管癌有一定的诊断价值,诊断效能较佳,NLR+CA19-9联合检测具有更好的诊断价值。

Objective

To investigate the diagnostic value of neutrophil/lymphocyte ratio (NLR) combined with CA19-9 for intrahepatic cholangiocarcinoma (ICC).

Methods

70 ICC patients (ICC group), 80 patients with benign bile duct lesions (benign lesion group) and 80 healthy subjects (control group) admitted to the Third Affiliated Hospital of Sun Yat-sen University from January 2012 to October 2017 were enrolled. The informed consents of all patients were obtained and the local ethical committee approval was received. In the ICC group, 44 patients were male and 26 female, aged (54±12) years on average. In the benign lesion group, 54 cases were male and 26 female, aged (55±13) years on average. In the control group, 52 patients were male and 28 female, aged (51±10) years on average. Upon the initial admission, blood routine test, CA19-9 and CA125 of the patients were collected and NLR and platelet/lymphocyte ratio (PLR) were calculated. The diagnostic efficiency of single and combined parameters for ICC was evaluated by the ROC curve.

Results

The area under ROC curve of NLR, PLR, CA19-9 and CA125 in diagnosis of ICC was 0.848, 0.780, 0.881 and 0.860, respectively. The diagnostic threshold values were 2.3, 168, 19 kU/L and 21 kU/L, respectively. The sensitivity of NLR, PLR, CA19-9 and CA125 was 0.81, 0.51, 0.74 and 0.67, respectively. The specificity of NLR, PLR, CA19-9 and CA125 was 0.86, 0.91, 0.98 and 0.90, respectively. The area under ROC curve of NLR+PLR, NLR+CA19-9, NLR+CA125 and CA19-9+CA125 was 0.857, 0.963, 0.927 and 0.938, respectively. The sensitivity was 0.86, 0.96, 0.93 and 0.89, and the specificity was 0.81, 0.88, 0.84 and 0.88, respectively.

Conclusions

Single detection of NLR, PLR, CA19-9 and CA125 is of certain value in the diagnosis of ICC with relatively high diagnostic efficiency. However, the combined detection of NLR and CA19-9 yields better diagnostic value compared with single parameter.

表1 胆管癌组、良性病变组和对照组NLR、PLR、CA19-9、CA125比较[MQR)]
表2 NLR、PLR、CA19-9、CA125对ICC的诊断效能评价
表3 NLR、PLR、CA19-9、CA125联合检测诊断ICC的效能评价
图1 NLR与CA19-9联合检测诊断ICC的ROC曲线
[1]
俞颖,谭潘丽,钱丽丽.肝内胆管癌患者血清蛋白指纹图谱的检测及其意义[J].中国卫生检验杂志,2010(4):808-810.
[2]
Shin HR, Oh JK, Masuyer E, Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia[J]. Asian Pac J Cancer Prev, 2010, 11(5):1159-1166.
[3]
盛家和,曹伟娟,焦扬.AFP、铁蛋白、CEA、CA199的联合检测对原发性肝癌的诊断[J].中国卫生检验杂志,2009, 19(10):2339-2341.
[4]
Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States[J]. Hepatology, 2001, 33(6): 1353-1357.
[5]
刘莉.胆汁CEA、CA199、CA50联合检测对胆管恶性肿瘤诊断价值的探讨[J].中国卫生检验杂志,2013, 23(6):1507-1509.
[6]
高正杰,王凤山.原发性肝内胆管癌的诊治现状[J].世界华人消化杂志,2015, 23(31):4939-4945.
[7]
胡永珍,孟樱,顾慧华,等.血清糖类抗原199在肝内胆管细胞癌中的检测意义[J].临床医学,2008, 28(6):111-112.
[8]
何建新,张金锋,王利健, 等. 糖链抗原199参考范围设置对胰腺、胆囊疾病诊断的影响[J].中国卫生检验杂志, 2018, 28(3):257-260.
[9]
陈漪,王志明,任正刚,等.CA19-9对肝细胞癌和胆管细胞癌的诊断价值[J].中华肝脏病杂志,2006, 14(4):299-300.
[10]
国际肝胆胰学会中国分会,中华医学会外科学分会肝脏外科学组.胆管癌诊断与治疗——外科专家共识[J].临床肝胆病杂志,2015(1):12-16.
[11]
覃怀成,陈希纲.应用ROC曲线评价CA19-9、CA125、CEA联合检测对肝内胆管细胞癌的诊断价值[J].实用医学杂志,2010, 26(10):1775-1777.
[12]
Azab B, Mohammad F, Shah N, et al. The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer[J]. Cancer Biomark, 2014, 14(5):303-312.
[13]
Chen TM, Lin CC, Huang PT, et al. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation[J]. J Gastroenterol Hepatol, 2012, 27(3):553-561.
[14]
Kao SC, Pavlakis N, Harvie R, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy[J]. Clin Cancer Res, 2010, 16(23):5805-5813.
[15]
Lee YH, Song GG. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: a meta-analysis[J]. Int J Rheum Dis, 2018, 21(12):2180-2187.
[16]
Luo Z, Zheng Y, Yang L, et al. Neutrophil/lymphocyte ratio is helpful for predicting weaning failure: a prospective, observational cohort study[J]. J Thorac Dis, 2018, 10(9):5232-5245.
[17]
Yoo JJ, Cho EJ, Lee B, et al. Prognostic value of biochemical response models for primary biliary cholangitis and the additional role of the neutrophil-to-lymphocyte ratio[J]. Gut Liver, 2018, 12(6): 714-721.
[18]
Zhang F, Qian J, Tao C, et al. Neutrophil to lymphocyte ratio predicts island sign in patients with intracranial hemorrhage[J]. Medicine, 2018, 97(44):e13057.
[19]
Kokulu K, Günaydın YK, Akıllı NB, et al. Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease[J]. Turk J Gastroenterol, 2018, 29(6):684-691.
[20]
Omichi K, Cloyd JM, Yamashita S, et al. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma[J]. Surgery, 2017, 162(4):752-765.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[3] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[4] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[5] 杨雪, 张伟, 尚培中, 宋创业, 尚丹丹, 张蔚. 胆囊十二指肠瘘结石经瘘口排出后自愈一例报道[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 707-708.
[6] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[7] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[8] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[9] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[10] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[11] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[12] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[13] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要